Innoviva
INVA
#5093
Rank
โ‚น141.45 B
Marketcap
โ‚น1,892
Share price
1.25%
Change (1 day)
16.56%
Change (1 year)

Revenue for Innoviva (INVA)

Revenue in 2025 (TTM): โ‚น33.62 Billion

According to Innoviva's latest financial reports the company's current revenue (TTM ) is โ‚น35.00 Billion. In 2024 the company made a revenue of โ‚น30.77 Billion an increase over the revenue in the year 2023 that were of โ‚น25.84 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Innoviva from 2005 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น33.62 B9.26%
2024 โ‚น30.77 B19.06%
2023 โ‚น25.84 B-5.74%
2022 โ‚น27.41 B-6%
2021 โ‚น29.16 B18.42%
2020 โ‚น24.63 B32.33%
2019 โ‚น18.61 B1.99%
2018 โ‚น18.25 B31.58%
2017 โ‚น13.86 B52.8%
2016 โ‚น9.07 B153.17%
2015 โ‚น3.58 B570.8%
2014 โ‚น0.53 B82.94%
2013 โ‚น0.29 B-96.07%
2012 โ‚น7.43 B473.22%
2011 โ‚น1.29 B19.47%
2010 โ‚น1.08 B-4.03%
2009 โ‚น1.13 B1.88%
2008 โ‚น1.11 B28.56%
2007 โ‚น0.86 B-0.47%
2006 โ‚น0.86 B59.93%
2005 โ‚น0.54 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
โ‚น20.36 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚น57.84 B 65.26%๐Ÿ‡บ๐Ÿ‡ธ USA